Investor Presentaiton
Adjusted EBITDA (twelve months ended)
Twelve Months Ended
($ in thousands)
Net income attributable to Albemarle Corporation
Depreciation and amortization
Non-recurring and other unusual items (excluding items associated with
interest expense)
Jun 30, 2021
Sep 30, 2021
Dec 31, 2021
Mar 31, 2022
Jun 30, 2022
703,213
212,131
$
123,672
$
281,378
263,551
244,132
247,535
254,000
258,314
267,884
(360,075)
291,102
481,194
478,490
885,605
Interest and financing expenses
89,413
75,322
61,476
45,428
79,685
Income tax expense
149,644
4,321
29,446
87,869
69,902
Non-operating pension and OPEB items
35,535
32,965
(78,814)
(78,629)
Adjusted EBITDA
861,862
863,376
870,974 $
1,072,850
$
(78,196)
1,488,431
Net impact of adjusted EBITDA from divested businesses
Adjusted EBITDA excluding impact from divested business
$
(66,657)
795,205
(44,866)
(28,415)
(6,990)
-
$
818,510 $
842,559 $
1,065,860 $
1,488,431
Net sales
$
3,229,202
Net impact of net sales from divested business
(162,290)
3,312,900 $
(120,095)
Net sales excluding impact from divested business
$
3,066,912
3,192,805
3,327,957
(65,648)
3,262,309
3,626,394
4,332,091
(21,191)
$
3,605,203
$ 4,332,091
Adjusted EBITDA margin excluding impact from divested businesses
26 %
26 %
26 %
30%
34 %
44
MAKING THE WORLD SAFE AND SUSTAINABLE
See above for a reconciliation of adjusted EBITDA and pro-forma adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to
Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.
See above for a reconciliation of pro-forma net sales, the non-GAAP financial measure, to net sales, the most directly comparable financial measure
calculated and reported in accordance with GAAP.
ALBEMARLEView entire presentation